• Maria João P Oliveira, Fernanda Rodrigues, João Firmino-Machado, Inês T Ladeira, Ricardo Lima, Sara D Conde, and Miguel Guimarães.
• Department of Pulmonology, Centro Hospitalar de Vila Nova de Gaia e Espinho, Entidade Pública Empresarial (EPE), Vila Nova de Gaia, Portugal. 6oliveiramariajoao@gmail.com.
• Respir Care. 2018 Oct 1; 63 (10): 1223-1230.

IntroductionNeuromuscular diseases (NMD) are a group of rare heterogeneous disorders that may be accompanied by respiratory muscle weakness. The simplest measurements of respiratory muscle strength are maximum inspiratory pressure (PImax) and maximum expiratory pressure (PEmax) of the mouth. Inspiratory muscle weakness can also be evaluated by the sniff test (sniff nasal inspiratory pressure method). This study tested the agreements in PImax and PEmax (measured by using a plethysmograph and portable equipment) as well as the correlations of PImax and PEmax by using the sniff nasal inspiratory pressure method, lung function, and arterial blood gas parameters in subjects with NMD.MethodsThis prospective, noninterventional study measured respiratory parameters in all the subjects with NMD who underwent measurement of maximum respiratory pressures.ResultsA total of 55 subjects with NMD were included. There were no statistically significant differences in PImax and PEmax measured by using a plethysmograph and portable equipment. Moreover, PImax showed a good correlation with the sniff nasal inspiratory pressure method.ConclusionsMeasurements of PImax and PEmax by using portable equipment were equivalent to those performed by using the accepted standard, plethysmography, in the subjects with NMD. Noninvasive evaluation of the sniff test with the portable equipment correlates with PImax, which makes this approach a good method for measuring the maximum strength of inspiratory muscles in patients with NMD.Copyright © 2018 by Daedalus Enterprises.

27 keywords...

hide…